- Home
- NMZ vs HROW Comparison
NMZ vs HROW Comparison
Compare NMZ & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMZ
- HROW
- Stock Information
- Founded
- NMZ 2003
- HROW 1998
- Country
- NMZ United States
- HROW United States
- Employees
- NMZ N/A
- HROW N/A
- Industry
- NMZ Finance/Investors Services
- HROW Biotechnology: Pharmaceutical Preparations
- Sector
- NMZ Finance
- HROW Health Care
- Exchange
- NMZ Nasdaq
- HROW Nasdaq
- Market Cap
- NMZ 1.2B
- HROW 1.3B
- IPO Year
- NMZ N/A
- HROW N/A
- Fundamental
- Price
- NMZ $11.05
- HROW $36.10
- Analyst Decision
- NMZ
- HROW Strong Buy
- Analyst Count
- NMZ 0
- HROW 4
- Target Price
- NMZ N/A
- HROW $55.00
- AVG Volume (30 Days)
- NMZ 356.8K
- HROW 307.5K
- Earning Date
- NMZ 01-01-0001
- HROW 11-13-2024
- Dividend Yield
- NMZ 5.08%
- HROW N/A
- EPS Growth
- NMZ N/A
- HROW N/A
- EPS
- NMZ N/A
- HROW N/A
- Revenue
- NMZ N/A
- HROW $169,138,000.00
- Revenue This Year
- NMZ N/A
- HROW $50.31
- Revenue Next Year
- NMZ N/A
- HROW $47.75
- P/E Ratio
- NMZ N/A
- HROW N/A
- Revenue Growth
- NMZ N/A
- HROW 48.15
- 52 Week Low
- NMZ $8.26
- HROW $9.13
- 52 Week High
- NMZ $11.14
- HROW $59.23
- Technical
- Relative Strength Index (RSI)
- NMZ 52.72
- HROW 49.93
- Support Level
- NMZ $10.76
- HROW $33.04
- Resistance Level
- NMZ $11.04
- HROW $36.13
- Average True Range (ATR)
- NMZ 0.12
- HROW 1.87
- MACD
- NMZ 0.03
- HROW 0.30
- Stochastic Oscillator
- NMZ 85.11
- HROW 72.98
About NMZ Nuveen Municipal High Income Opportunity Fund $0.01 par value per share
Nuveen Municipal High Income Opp Fund is a diversified, closed-end management investment company. The company's investment objectives is to provide current income exempt from regular federal income tax by investing predominantly in a portfolio of municipal obligations issued by state and local government authorities or certain U.S. territories. It seeks to provide attractive monthly tax-free income, portfolio diversification and attractive after tax total returns. The fund invests in municipal securities that are exempt from federal income taxes.
About HROW Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans.